TentaMedix extends its GMP portfolio

Pyrogen testing methods have been successfully inspected by the Regierungspräsidium Tübingen as GMP compliant (Regional Council Tübingen)

ID: 1563849
recent pressrelease next pressrelease

(PresseBox) - TentaMedix GmbH is pleased to announce the extension of its GMP relevant testing portfolio. Already in the year 2019, TentaMedix GmbH received the official certificate of recognition from the ZLG and the listing as an officially recognised testing laboratory for medical devices in accordance with the requirements of Directives 93/42/EEC, 90/385/EEC, and DIN ISO/IEC 17025 for biological and microbiological testing of medical devices.

The extension of the GMP compliant portfolio now also includes the methods already accredited by ZLG for in vitro testing for bacterial endotoxins using the Limulus amebocyte lysate test (LAL; Ph. Eur. 2.6.14; methods C & D) as well as detection for pyrogens using the monocyte activation test (MAT; Ph. Eur. 2.6.30) for medicinal products.

Managing Director Dr. Dominik Herzog commented: ?The extension of the GMP testing methods is a great achievement by every single employee of our contract laboratory. Our focus remains on the 3Rs (reduce, replace, refine) to reduce the number of unnecessary animal experiments. Implementing additional testing methods helps us to investigate the biosafety of medical devices and drugs for manufacturers and ultimately for patient safety.?

The authorised signatory of TentaMedix GmbH Dr. Wolfgang Rudy is also pleased: ?Having the pyrogenicity tests GMP compliant is a great success. Now we can also carry out drug testing in this area in addition to medical devices. We are constantly working on improving ourselves. For example, we are planning to expand the existing ISO 10993 services to include the in vitro micronucleus test. In combination with the already accredited AMES test, we will be able to completely offer the required in vitro genotoxicity testing of ISO 10993-3 or ISO 10993-33 in the near future.?

TentaMedix GmbH already offers a wide range of ISO 17025 accredited and ZLG recognised test methods for biocompatibility testing according to ISO 10993 for medical devices. With the extension of the GMP compliant portfolio, TentaMedix GmbH further establishes itself as a relevant testing laboratory for medical devices and pharmaceuticals.



Would you like to learn more about TentaMedix? services? Please feel free to contact our expert directly, we will be happy to support you.

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 70 locations worldwide. More than 3,000 highly-trained staff members work in over 3 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Tentamus Group

An der Industriebahn 5

13088 Berlin, Germany

www.tentamus.com



More information:
http://https://www.prolandscapinghobart.com/ https://



Keywords (optional):



Company information / Profile:

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food&feed, pharmaceuticals&medical, agrosciences, cosmetics, agriculture&environment and nutraceutical&supplements). Tentamus Group is represented in over 70 locations worldwide. More than 3,000 highly-trained staff members work in over 3 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.Tentamus GroupAn der Industriebahn 513088 Berlin, Germanywww.tentamus.com

PressRelease by

Requests:



PressContact / Agency:



published by: PresseBox
print pressrelease  send to a friend  

Date: 01/18/2021 - 02:54
Language: English
News-ID 1563849
Character count: 3860
Kontakt-Informationen:
Firma: Tentamus Group GmbH
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: Karlsruhe
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 233

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 439
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 71


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.